X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sarcopenia (7) 7
cancer (6) 6
index medicus (6) 6
oncology (6) 6
chemotherapy (5) 5
aged (4) 4
female (4) 4
humans (4) 4
muscle mass (4) 4
overall survival (4) 4
breast cancer (3) 3
breast neoplasms - drug therapy (3) 3
breast neoplasms - pathology (3) 3
cancer patients (3) 3
care and treatment (3) 3
middle aged (3) 3
neoadjuvant chemotherapy (3) 3
prognosis (3) 3
skeletal-muscle (3) 3
adult (2) 2
body composition (2) 2
body-composition (2) 2
breast neoplasms - mortality (2) 2
clinical-outcomes (2) 2
colorectal-cancer (2) 2
elderly-patients (2) 2
hepatocellular-carcinoma (2) 2
low muscle mass (2) 2
medicine & public health (2) 2
metastasis (2) 2
metastatic breast cancer (2) 2
muscle attenuation (2) 2
muscle, skeletal - diagnostic imaging (2) 2
muscles (2) 2
neoplasm metastasis (2) 2
pancreatic-cancer (2) 2
research (2) 2
sarcopenic obesity (2) 2
solid tumors (2) 2
5-fluorouracil (1) 1
activities of daily living (1) 1
activities of daily living - psychology (1) 1
adipose tissue (1) 1
adipose tissue - diagnostic imaging (1) 1
adipose tissue - drug effects (1) 1
adipose tissues (1) 1
adjuvant treatment (1) 1
aged patients (1) 1
aged, 80 and over (1) 1
aging (1) 1
anthracycline (1) 1
anthracyclines (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
biomarkers, tumor - genetics (1) 1
body composition - drug effects (1) 1
breast neoplasms - complications (1) 1
breast neoplasms - genetics (1) 1
bridged-ring compounds - administration & dosage (1) 1
cancer research (1) 1
cancer therapies (1) 1
carcinoma (1) 1
chemotherapy, adjuvant - adverse effects (1) 1
clinical trials as topic (1) 1
cohort studies (1) 1
computed-tomography (1) 1
cyclophosphamide (1) 1
cyclophosphamide - adverse effects (1) 1
determinant (1) 1
diffuse large b-cell lymphoma (1) 1
disease-free survival (1) 1
docetaxel (1) 1
doxorubicin (1) 1
doxorubicin - adverse effects (1) 1
elderly (1) 1
esophageal (1) 1
esophagogastric cancer (1) 1
fluorouracil (1) 1
fluorouracil - adverse effects (1) 1
functional tests (1) 1
gastric-cancer (1) 1
geriatric oncology (1) 1
health (1) 1
health care sciences & services (1) 1
hematology, oncology and palliative medicine (1) 1
human epidermal growth receptor 2 positive (1) 1
humanities (1) 1
kaplan-meier estimate (1) 1
lean body-mass (1) 1
male (1) 1
mass (1) 1
mass index (1) 1
medical prognosis (1) 1
medical research (1) 1
medicine, experimental (1) 1
metastases (1) 1
mortality (1) 1
muscle density (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The oncologist (Dayton, Ohio), ISSN 1549-490X, 2016, Volume 21, Issue 11, pp. 1396 - 1409
In several diseases, low muscle mass has been revealed as an unfavorable prognostic factor for outcome. Whether this holds true in patients with solid... 
Sarcopenia | Low muscle mass | Chemotherapy | Cancer | LEAN BODY-MASS | OLDER-ADULTS | COMPUTED-TOMOGRAPHY | SKELETAL-MUSCLE | HEPATOCELLULAR-CARCINOMA | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | NUTRITIONAL-STATUS | GASTRIC-CANCER | SARCOPENIC OBESITY | SEVERE POSTOPERATIVE COMPLICATIONS | Symptom Management and Supportive Care
Journal Article
Breast cancer research and treatment, ISSN 1573-7217, 2017, Volume 168, Issue 1, pp. 95 - 105
Journal Article
Journal Article
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, Volume ahead-of-print, Issue ahead-of-print, pp. 1 - 9
Low muscle mass (LMM) and low muscle density (LMD) are increasingly recognized as prognostic factors for survival in different malignancies. This study... 
overall survival | diffuse large B-cell lymphoma | muscle density | Muscle mass | sarcopenia
Journal Article
Journal Article
11/2016, Volume 21, Issue 11
In several diseases, low muscle mass has been revealed as an unfavorable prognostic factor for out come. Whet her this holds true in patients with solid... 
Sarcopenia | Chemotherapy | Low muscle mass | Oncology | Cancer Research | Cancer
Publication
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.